In the world of high-performance chromatography, achieving consistent, high-resolution results is the ultimate goal for any serious analyst. Over the years, I have experimented with v Waters Corp ACQUITY UPLC Peptide CSH C18 Column arious stationary phases, but my recent shift to the ACQUITY UPLC Peptide CSH C18 has fundamentally changed my workflow. This column has become a cornerstone of my laboratory setup, particularly when dealing with complex mixtures that demand superior peak shape and reproducibility.
The Technolo U(H)PLC Column ACQUITY Peptide CSH C18, 130 Å, 1.7 gical Edge: Understanding CSH
What sets the ACQUITY UPLC Peptide CSH C18 column apart is the proprietary Charged Surface Hybrid (CSH) technology. Unlike traditional silica-based phases, ACQUITY UPLC CSH columns feature Waters Charged Surface Hybrid (CSH) Technology, which incorporates a low, carefully defined concentration of positive charges into the surface.
From my personal observations, this innovation is a game-changer. It provides excellent peak shape and high loading capacity, even when working with basic compounds that typically exhibit tailing on standar What is the difference between ACQUITY UPLC Peptide d C18 chemistries. I have found that these columns are excellent for challenging separations, which is why they are my go-to choice for demanding applications.
Performance and Specifications
When integrating the Waters ACQUITY UPLC CSH130 C18 1.7 µm particles into my system, the difference in efficiency is immediate. The 1.7 µm particle size ensures that the system operates with the high efficiency required for modern UPLC workflows.
I often utilize the ACQUITY UPLC and ACQUITY PREMIER Peptide CSH C18 configurations, as they offer remarkable stability. Whether I am using formic acid (FA) or trifluoroacetic acid (TFA) in my mobile phase, the column maintains its selectivity. This versatility is crucial, especially when I am running the one ACQUITY UPLC CSH130 C18 column provided in the kit alongside t ACQUITY UPLC CSH Columns Care and Use Manual he Cytochrome C Digestion Standard to verify system suitability.
Quality Assurance and Reproducibility
One of the most critical factors for me is batch-to-batch consistency. It is reassuring to know that ACQUITY CSH C18 columns are batch QC tested with a small-molecule mix. This rigorous testing ensures that the ACQUITY UPLC Peptide CSH C18 column performs identically every time I swap it out.
While comparing this to other ch U(H)PLC Column ACQUITY Peptide CSH C18, 130 Å, 1.7 emistries—such as the ACQUITY UPLC Peptide BEH C18—I have noticed that the CSH chemistry provides a unique selectivity profile that is particularly beneficial for peptide mapping. The WATERS ACQUITY UPLC CSH C18 Chromatography Column is not just a tool; it is a reliable standard that allows for the precise analysis of complex samples.
Why I Prefer the Peptide CSH C18
The Peptide CSH chemistry, combined with the C18 hydrophobic ligand, creates a robust environment for separation. I have found that the ACQUITY UPLC system, when paired with these columns, delivers maximum performance. Because the ACQUITY CSH Columns feature Waters Charged Surface Hybrid (CSH) Technology, I spend significantly less time troubleshooting peak shapes and more time interpreting data.
For those looking to upgrade their UPLC capabilities, I highly recommend looking into the ACQUITY UPLC Peptide CSH C18 column. It is a sophisticated piece of engineering that balances loading capacity and resolution, making it an essential component for any high-throughput laboratory. My experience has been that o ACQUITY UPLC and ACQUITY PREMIER CSH Columns nce you transition to this specific column, the difference Price: £1,209.00. Qty. WatersACQUITY UPLCCSH130C181.7 µm particles contain a low and carefully-defined concentration of positive charges that yield Read more in peak symmetry and overall analytical confidence is undeniable.